BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17655961)

  • 1. Testosterone 15beta-hydroxylation by solvent tolerant Pseudomonas putida S12.
    Ruijssenaars HJ; Sperling EM; Wiegerinck PH; Brands FT; Wery J; de Bont JA
    J Biotechnol; 2007 Aug; 131(2):205-8. PubMed ID: 17655961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Process development for the production of 15β-hydroxycyproterone acetate using Bacillus megaterium expressing CYP106A2 as whole-cell biocatalyst.
    Kiss FM; Lundemo MT; Zapp J; Woodley JM; Bernhardt R
    Microb Cell Fact; 2015 Mar; 14():28. PubMed ID: 25890176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP106A2-A versatile biocatalyst with high potential for biotechnological production of selectively hydroxylated steroid and terpenoid compounds.
    Schmitz D; Janocha S; Kiss FM; Bernhardt R
    Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):11-22. PubMed ID: 28780179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solvent resistance pumps of Pseudomonas putida S12: Applications in 1-naphthol production and biocatalyst engineering.
    Janardhan Garikipati SV; Peeples TL
    J Biotechnol; 2015 Sep; 210():91-9. PubMed ID: 26143210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodesulfurization in biphasic systems containing organic solvents.
    Tao F; Yu B; Xu P; Ma CQ
    Appl Environ Microbiol; 2006 Jul; 72(7):4604-9. PubMed ID: 16820450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redundancy in putrescine catabolism in solvent tolerant Pseudomonas putida S12.
    Bandounas L; Ballerstedt H; de Winde JH; Ruijssenaars HJ
    J Biotechnol; 2011 Jun; 154(1):1-10. PubMed ID: 21540064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical and experimental evaluation of a CYP106A2 low homology model and production of mutants with changed activity and selectivity of hydroxylation.
    Lisurek M; Simgen B; Antes I; Bernhardt R
    Chembiochem; 2008 Jun; 9(9):1439-49. PubMed ID: 18481342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
    Peters MW; Meinhold P; Glieder A; Arnold FH
    J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering of CYP106A2 for steroid 9α- and 6β-hydroxylation.
    Nikolaus J; Nguyen KT; Virus C; Riehm JL; Hutter M; Bernhardt R
    Steroids; 2017 Apr; 120():41-48. PubMed ID: 28163026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of solvent tolerance in Pseudomonas putida S12 mediated by mobile elements.
    Hosseini R; Kuepper J; Koebbing S; Blank LM; Wierckx N; de Winde JH
    Microb Biotechnol; 2017 Nov; 10(6):1558-1568. PubMed ID: 28401676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function and engineering of the 15beta-hydroxylase CYP106A2.
    Virus C; Lisurek M; Simgen B; Hannemann F; Bernhardt R
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1215-8. PubMed ID: 17073788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxylation of testosterone by bacterial cytochromes P450 using the Escherichia coli expression system.
    Agematu H; Matsumoto N; Fujii Y; Kabumoto H; Doi S; Machida K; Ishikawa J; Arisawa A
    Biosci Biotechnol Biochem; 2006 Jan; 70(1):307-11. PubMed ID: 16428858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient hydroxylation of 1,8-cineole with monoterpenoid-resistant recombinant Pseudomonas putida GS1.
    Mi J; Schewe H; Buchhaupt M; Holtmann D; Schrader J
    World J Microbiol Biotechnol; 2016 Jul; 32(7):112. PubMed ID: 27263007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid conversion with CYP106A2 - production of pharmaceutically interesting DHEA metabolites.
    Schmitz D; Zapp J; Bernhardt R
    Microb Cell Fact; 2014 Jun; 13():81. PubMed ID: 24903845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the proteome response to toluene exposure in the solvent tolerant Pseudomonas putida S12.
    Wijte D; van Baar BL; Heck AJ; Altelaar AF
    J Proteome Res; 2011 Feb; 10(2):394-403. PubMed ID: 20979388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards preparative scale steroid hydroxylation with cytochrome P450 monooxygenase CYP106A2.
    Zehentgruber D; Hannemann F; Bleif S; Bernhardt R; Lütz S
    Chembiochem; 2010 Mar; 11(5):713-21. PubMed ID: 20183841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of prednisone and dexamethasone by cytochrome P450 based systems - Identification of new potential drug candidates.
    Putkaradze N; Kiss FM; Schmitz D; Zapp J; Hutter MC; Bernhardt R
    J Biotechnol; 2017 Jan; 242():101-110. PubMed ID: 27988215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic Response of Pseudomonas putida S12 to Sudden Addition of Toluene and the Potential Role of the Solvent Tolerance Gene trgI.
    Volkers RJ; Snoek LB; Ruijssenaars HJ; de Winde JH
    PLoS One; 2015; 10(7):e0132416. PubMed ID: 26181384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic response of Pseudomonas putida during redox biocatalysis in the presence of a second octanol phase.
    Blank LM; Ionidis G; Ebert BE; Bühler B; Schmid A
    FEBS J; 2008 Oct; 275(20):5173-90. PubMed ID: 18803670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.